Dr Otto Metzger (IMAGE)
Caption
New results to be presented at the 12th European Breast Cancer Conference show that a test, which looks at the activity of 70 genes in breast cancer tissue, is possible to use in the clinic to identify patients with invasive lobular carcinoma (ILC) that is at high risk of recurring and progressing.
Credit
Otto Metzger
Usage Restrictions
None
License
Licensed content